PPIA; CyP-A; CYPH; Peptidylprolyl Isomerase A; Peptidyl-Prolyl Isomerase A; Peptidyl-prolyl cis-trans isomerase A; Cyclosporin A-binding protein
Thy1; CDw90; THY mocyte differentiation antigen 1
SCAN1; SHAPY; CAN1; Soluble Ca-Activated Nucleotidase,Isozyme 1; Apyrase homolog; Putative MAPK-activating protein PM09; Putative NF-kappa-B-activating protein 107
CD25; IL2R-a; IL2-RA; IDDM10; IL2R; TCGFR; p55; TAC antigen
HLA-DRB1; MHCDRb1; HLADRb1; Major Histocompatibility Complex Class II DR Beta 1; HLA Class II Histocompatibility Antigen,DRB1-9 Beta Chain; HLA class II histocompatibility antigen, DRB1-15 beta chain
FceRII; FCER2; BLAST-2; CLEC4J; FCE2; IGEBF; Receptor II For The Fc Region Of Immunoglobulin E; C-type lectin domain family 4 member J; Immunoglobulin E-binding factor; Lymphocyte IgE receptor
MOX1; MOX2; MRC; OX-2; My033; Antigen Identified By Monoclonal Antibody MRC OX-2
CD274; PDCD1LG1; B7-H; B7H1; PD-L1; PDCD1L1; PDCD1-LG1; Programed Death Ligand 1
MS4A1; MS4-A1; B1; Bp35; LEU16; MS4-A2; S7; B-lymphocyte antigen CD20; B-lymphocyte surface antigen B1
PTPRC; PTPR-C; LCA; B220; GP180; LY5; T200; Leukocyte common antigen
MHC-B; HLA-B; HLAB; AS; SPDA1; Leukocyte Antigen B; Ankylosing Spondylitis; HLA class I histocompatibility antigen, B-7 alpha chain
LANP; MAPM; PHAP1; C15orf1; Mapmodulin; Leucine-rich acidic nuclear protein; Putative HLA-DR-associated protein I; Potent heat-stable protein phosphatase 2A inhibitor I1PP2A